NFKB1 and Alzheimer disease: In animal experiments (He, 2023), DHA, the first-generation derivative of artemisinin, was found to inhibit the TLR4/MyD88/NF-kB pathway, reduce the inflammatory response in the hippocampal tissue of 6-month-old AD model mice, and decrease the permeability of the blood-brain barrier.